Anti-FACL4 antibody - Aminoterminal end (ab70937)

Overview

  • Product nameAnti-FACL4 antibody - Aminoterminal end
    See all FACL4 primary antibodies
  • Description
    Rabbit polyclonal to FACL4 - Aminoterminal end
  • Tested applicationsSuitable for: WB, ELISA, IHC-Pmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    A KLH conjugated synthetic peptide selected from the N-terminal region of human FACL4.

  • Positive control
    • Human hepatocarcinoma tissue and 293 cell lysate.

Properties

Applications

Our Abpromise guarantee covers the use of ab70937 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB
ELISA
IHC-P
  • Application notesELISA: 1/1000.
    IHC-P: 1/50 - 1/100.
    WB: 1/100 - 1/500. Detects bands of approximately 28, 30 and 65 kDa (predicted molecular weight: 79 kDa).


    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • FunctionActivation of long-chain fatty acids for both synthesis of cellular lipids, and degradation via beta-oxidation. Preferentially uses arachidonate and eicosapentaenoate as substrates.
    • Involvement in diseaseDefects in ACSL4 are the cause of mental retardation X-linked type 63 (MRX63) [MIM:300387]. Mental retardation is a mental disorder characterized by significantly sub-average general intellectual functioning associated with impairments in adaptative behavior and manifested during the developmental period. Non-syndromic mental retardation patients do not manifest other clinical signs.
      Defects in ACSL4 are involved in Alport syndrome with mental retardation midface hypoplasia and elliptocytosis (ATS-MR) [MIM:300194]. A X-linked contiguous gene deletion syndrome characterized by glomerulonephritis, deafness, mental retardation, midface hypoplasia and elliptocytosis.
    • Sequence similaritiesBelongs to the ATP-dependent AMP-binding enzyme family.
    • Cellular localizationMitochondrion outer membrane. Peroxisome membrane. Microsome membrane. Endoplasmic reticulum membrane.
    • Information by UniProt
    • Database links
    • Alternative names
      • ACS 4 antibody
      • ACS4 antibody
      • ACSL 4 antibody
      • Acsl4 antibody
      • ACSL4_HUMAN antibody
      • acyl CoA synthetase 4 antibody
      • Acyl CoA synthetase long chain family member 4 antibody
      • FACL 4 antibody
      • FACL4 antibody
      • Fatty acid Coenzyme A ligase antibody
      • fatty acid Coenzyme A ligase long-chain 4 antibody
      • LACS 4 antibody
      • LACS4 antibody
      • Lignoceroyl CoA synthase antibody
      • Long chain 4 antibody
      • long chain acyl CoA synthetase 4 antibody
      • long chain fatty acid CoA ligase 4 antibody
      • long chain fatty acid Coenzyme A ligase 4 antibody
      • Long-chain acyl-CoA synthetase 4 antibody
      • Long-chain-fatty-acid--CoA ligase 4 antibody
      • MRX63 antibody
      • MRX68 antibody
      see all

    Anti-FACL4 antibody - Aminoterminal end images

    • Anti-FACL4 antibody - Aminoterminal end (ab70937) at 1/100 dilution + 293 cell lysate at 12.5 µg

      Predicted band size : 79 kDa
      Observed band size : 65 kDa (why is the actual band size different from the predicted?)
      Additional bands at : 28 kDa,30 kDa. We are unsure as to the identity of these extra bands.
    • Formalin-fixed, paraffin-embedded human hepatocarcinoma tissue reacted with ab70937 at a 1:50 dilution, which was peroxidase-conjugated to the secondary antibody, followed by DAB staining.

    References for Anti-FACL4 antibody - Aminoterminal end (ab70937)

    ab70937 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab70937.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"